iShares Micro-Cap ETF
Price through Sep 30 · Flows through Sep 29. Figures use the latest available records, not a live quote. Fund details retrieved Oct 1. Holdings snapshot retrieved Oct 1.
The fund invests at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 1Y SHOWN · NET +$115M OVER THIS RANGE
Money is leaving — −$75M in net outflows over the past month, about 5.6% of the fund's asset base, while the price has returned +17.4% so far this year. At 0.60% a year it is not the cheapest way in — FDHT has a reported fee of 0.39%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | CDNACAREDX | 0.77% | $66.23 | +1.9% | ||
| 2 | PENGPenguin Solutions | 0.66% | $54.98 | +0.5% | ||
| 3 | OUSTOUSTER | 0.62% | $40.87 | +1.3% | ||
| 4 | PURRHyperliquid Strategies | 0.54% | $12.03 | -2.0% | ||
| 5 | INODINNODATA | 0.50% | $71.85 | +9.3% | ||
| 6 | SLSSELLAS LIFE SCIENCES GROUP | 0.54% | $11.33 | -8.0% | ||
| 7 | ASSTASSET ENTITIES | 0.52% | $30.11 | +2.4% | ||
| 8 | NRIXNURIX THERAPEUTICS | 0.53% | $23.34 | -1.6% | ||
| 9 | TILEINTERFACE | 0.48% | $34.45 | +0.1% | ||
| 10 | VRDNVIRIDIAN THERAPEUTICS | 0.47% | $18.99 | -7.8% | ||
| 11 | BFLYBUTTERFLY NETWORK | 0.47% | $8.53 | -4.8% | ||
| 12 | BANDBANDWIDTH | 0.43% | $62.44 | +2.8% | ||
| 13 | MBXMBX Biosciences | 0.42% | $56.55 | -3.5% | ||
| 14 | ALNTALLIENT INC | 0.39% | $115.95 | +3.9% | ||
| 15 | URGNUROGEN PHARMA | 0.40% | $40.55 | -0.2% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 1473| 1 week | -1.4% |
| 1 month | -3.4% |
| 3 months | -7.6% |
| 6 months | +20.8% |
| YTD | +17.4% |
| 1 year | +23.9% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | −$37M |
| 1 month | −$75M |
| 3 months | −$44M |
| YTD | +$66M |
| 1 year | +$115M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 0.8% of the book; the top ten carry 6%. Spread across 250+ names, it behaves like roughly 208 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| ASST ASSET ENTITIES | $2M | $6M |
| INOD INNODATA | $3M | $2M |
| SLS SELLAS LIFE SCIENCES GROUP | $1M | $2M |
| UMAC UNUSUAL MACHINES INC | $682,060 | $1M |
| OUST OUSTER | $508,525 | $1M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat IWC on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW State Street SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.5B | +$286M | -57bp on fee · 31× the assets · +$286M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.2B | +$199M | -57bp on fee · 13× the assets · +$199M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.9B | +$497M | -56bp on fee · 24× the assets · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$575M | -56bp on fee · 18× the assets · +$575M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.6B | +$412M | -56bp on fee · 14× the assets · +$412M in over the month | Head-to-head |